Updates from The Motley Fool

Latest updates on CEL-SCI Corp from Fool.com.

Stock Performance

CVM vs. S&P 500 | 2 Year Performance
CVM 1-Day Stock Chart
CVM 5-Day Stock Chart
CVM 1-Month Stock Chart
CVM 3-Month Stock Chart
CVM 6-Month Stock Chart
CVM 1-Year Stock Chart
CVM 2-Year Stock Chart
CVM 5-Year Stock Chart
View Interactive CVM Charts
Sponsored by

Key Data Points

Primary metrics and data points about CEL-SCI Corp.
Current Price: $0.50
Prev Close: $0.50
Open: $0.50
Bid: $0.50
Ask: $0.50
Day's Range: $0.50 - $0.50
52wk Range: $0.36 - $0.80
Volume: 118,014
Avg Vol 342,509
Market Cap: $65.00M
P/E (ttm): -1.92
EPS (ttm): -$0.26
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CEL-SCI Corp.
CAPS Rating 1 out of 5
91 Outperform
20 Underperform
CAPS All Stars
8 Outperform
5 Underperform

How do you think CEL-SCI Corp will perform against the market?

You pick for CEL-SCI Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Geert R. Kersten, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for CEL-SCI Corp.

The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers